Saravana P. Selvanathan

Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing

Saravana P. Selvanathan, Garrett T. Graham, Hayriye V. Erkizan et al. · Proceedings of the National Academy of Sciences · 2015 · 144 citations · Full text

Medicine, Molecular Biology, Oncology +17

Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1

Julie S. Barber-Rotenberg, Saravana P. Selvanathan, Yali Kong et al. · Oncotarget · 2012 · 99 citations · Full text

Medicine, Cancer Biology, Oncology +7

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Filippo Spriano, Elaine Y. Chung, Eugenio Gaudio et al. · Clinical Cancer Research · 2019 · 69 citations

Medicine, Oncology, Pharmacology +17

Inhibition of the oncogenic fusion protein EWS-FLI1 causes G ₂ -M cell cycle arrest and enhanced vincristine sensitivity in Ewing’s sarcoma

Stefan Zöllner, Saravana P. Selvanathan, Garrett T. Graham et al. · Science Signaling · 2017 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

EWS–FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex

Saravana P. Selvanathan, Garrett T. Graham, Alexander Grego et al. · Nucleic Acids Research · 2019 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +17